MetLife (MET) director Laura J. Hay receives 587-share stock compensation grant

Rhea-AI Filing Summary

Hay Laura J reported acquisition or exercise transactions in this Form 4 filing.

MetLife Inc. director Laura J. Hay received an award of 587 shares of MetLife common stock as part of non-management director compensation. The shares were valued at $87.40 per share on the grant date. Following this award, Hay directly holds 6,318 shares of MetLife common stock. According to the disclosure, she elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the grant is part of standard board retainer fees rather than an open-market purchase.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Hay Laura J

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	587	$87.40	$51K

Holdings After Transaction: Common Stock — 6,318 shares (Direct, null)

Footnotes (1)

1. [object Object]

Key Figures

Stock award size: 587 shares Grant price: $87.40 per share Post-transaction holdings: 6,318 shares

3 metrics

Stock award size 587 shares Common stock grant to director on 2026-06-16

Grant price $87.40 per share Valuation of director stock award

Post-transaction holdings 6,318 shares Laura J. Hay direct MetLife common stock after award

Key Terms

non-management director compensation arrangements, retainer fees, MetLife Deferred Compensation Plan for Non-Management Directors, grant, award, or other acquisition

4 terms

non-management director compensation arrangements financial

"MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."

retainer fees financial

"non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock."

MetLife Deferred Compensation Plan for Non-Management Directors financial

"The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors."

grant, award, or other acquisition financial

"transaction_code_description: Grant, award, or other acquisition"

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Hay Laura J

(Last) (First) (Middle)

METLIFE, INC.

200 PARK AVENUE

(Street)

NEW YORK NEW YORK 10166

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
METLIFE INC [ MET ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/16/2026		A(1)		587	A	$87.4	6,318	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.

Remarks:

	/s/ Taylor McInerney Jansen, Attorney-in-fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did MetLife (MET) director Laura J. Hay report?

Laura J. Hay reported receiving 587 MetLife common shares as compensation. The award reflects non-management director retainer fees, not an open-market purchase, and is structured as a stock grant linked to her board service at MetLife Inc.

At what price was Laura J. Hay’s MetLife (MET) stock award valued?

The 587-share award to Laura J. Hay was valued at $87.40 per MetLife share. This value represents the grant price used for the compensation award under MetLife’s non-management director arrangements disclosed in the filing.

How many MetLife (MET) shares does Laura J. Hay hold after this Form 4 transaction?

After the reported grant, Laura J. Hay holds 6,318 MetLife common shares directly. This total includes the newly awarded 587 shares and represents her direct ownership position following the non-management director compensation transaction.

Was Laura J. Hay’s MetLife (MET) transaction an open-market buy or a compensation grant?

The transaction was a compensation grant, not an open-market buy. The filing describes it as a non-management director retainer fee paid in MetLife common stock, categorized as a grant, award, or other acquisition rather than a discretionary market purchase.

Did Laura J. Hay defer her MetLife (MET) stock award under a company plan?

Yes. The filing states she elected to defer receipt of the awarded shares under the MetLife Deferred Compensation Plan for Non-Management Directors, meaning the shares are credited under that plan instead of being immediately received.